Literature DB >> 17584045

Peroxisome proliferator-activated receptor-gamma in vascular biology.

Jingjue Li1, Nanping Wang.   

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) belongs to a family of ligand-activated nuclear receptor and transcription factors. The essential roles of PPAR-gamma in controlling metabolic processes have been underscored by the successful use of PPAR-gamma agonists thiazolidinediones to treat insulin resistance, a central feature of metabolic syndrome. PPAR-gamma is also expressed in the vascular tissues including endothelial cells (ECs), smooth muscle cells (SMCs) and macrophages. Increasing evidence suggests that PPAR-gamma is implicated both in the maintenance of vascular homeostasis and in the pathogenesis of a number of vascular conditions such as atherosclerosis, hypertension and restenosis. As an important regulator of vascular biology, PPAR-gamma may represent a potential therapeutic target for these metabolic vascular disorders. This review will focus on the recent advances related to the biological functions of PPAR-gamma in various vascular processes as well as the significances of the pharmacological activators/modulators of this metabolic nuclear receptor in vascular disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584045     DOI: 10.2174/187152907780830932

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  6 in total

Review 1.  PCSK9 and Other Metabolic Targets to Counteract Ischemia/Reperfusion Injury in Acute Myocardial Infarction and Visceral Vascular Surgery.

Authors:  Silvia Ortona; Chiara Barisione; Pier Francesco Ferrari; Domenico Palombo; Giovanni Pratesi
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

2.  Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes.

Authors:  Servio H Ramirez; David Heilman; Brenda Morsey; Raghava Potula; James Haorah; Yuri Persidsky
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 3.  Peroxisome proliferator-activated receptors for hypertension.

Authors:  Daisuke Usuda; Tsugiyasu Kanda
Journal:  World J Cardiol       Date:  2014-08-26

4.  Peroxisome Proliferator-Activated Receptor γ Regulates the Expression of Lipid Phosphate Phosphohydrolase 1 in Human Vascular Endothelial Cells.

Authors:  Yazi Huang; Beilei Zhao; Yahan Liu; Nanping Wang
Journal:  PPAR Res       Date:  2014-05-12       Impact factor: 4.964

5.  Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.

Authors:  Dengfeng Gao; Guanghua Hao; Zhe Meng; Ning Ning; Guang Yang; Zhongwei Liu; Xin Dong; Xiaolin Niu
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

6.  Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors.

Authors:  Yahan Liu; Xiao Yu Tian; Yu Huang; Nanping Wang
Journal:  PPAR Res       Date:  2014-02-18       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.